Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Kappa Opioid Receptor ELISA Kit (AC3946)
Cat.#: ASET-2535
Specifications
Description Mouse Kappa Opioid Receptor ELISA Kit allows for the in vitro quantitative determination of mouse Kappa Opioid Receptor concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1506 Human PKC gamma ELISA Kit (AC2917) Quantitative inquiry ASET-1786 Human NK-1R ELISA Kit (AC3197) Quantitative inquiry ASET-1250 Human ASIP ELISA Kit (AC2661) Quantitative inquiry ASET-1338 Human FOXO1A ELISA Kit (AC2749) Quantitative inquiry ASET-1586 Mouse GFAP ELISA Kit (AC2997) Quantitative inquiry ASET-1531 Human PSD95 ELISA Kit (AC2942) Quantitative inquiry ASET-1655 Rat GDNF ELISA Kit (AC3066) Quantitative inquiry ASET-1717 Mouse DLL4 ELISA Kit (AC3128) Quantitative inquiry ASET-2129 Human Hyaluronan Synthase 2 ELISA Kit (AC3540) Quantitative inquiry ASET-1645 Human CD24 ELISA Kit (AC3056) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket